Product Information

FT IBUPROFEN 200 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0329 per EA under NDC 70677113201. Its NADAC has been published 99 times since Oct 2, 2024.

FDA first approved this application on Dec 8, 1987.

The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FT IBUPROFEN 200 MG TABLET

Ibuprofen
$0.0329per EA
High Outlier
OTC

Strength

200 mg/1

NDC

70677113201

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA072096

FDA Approved

12/8/1987

On Market Since

9/15/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT IBUPROFEN 200 MG TABLET has been published 99 times since Oct 2, 2024, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0329 per EA
All-time high$0.0370 (Nov 12, 2025)
All-time low$0.0313 (May 21, 2025)
52-week high$0.0370
52-week low$0.0320
Median price$0.0337
Average price$0.0339
Largest weekly change-5.2% (Dec 17, 2025)
Weeks tracked99
Tracking sinceOct 2, 2024

Price History

1W

+2.0%

1M

+2.6%

3M

+1.9%

6M

+1.6%

1Y

-8.8%

3Y

N/A

5Y

N/A

All

-10.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT IBUPROFEN 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FT IBUPROFEN 200 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0329 per EA (NDC 70677113201), effective Aug 19, 2026.

How has the price of FT IBUPROFEN 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for FT IBUPROFEN 200 MG TABLET has declined 10.9%. It has been tracked across 99 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for FT IBUPROFEN 200 MG TABLET?

Since Oct 2, 2024, the NADAC for FT IBUPROFEN 200 MG TABLET has ranged from a low of $0.0313 (May 21, 2025) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0337 per EA.

Are there cheaper alternatives to FT IBUPROFEN 200 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 18% below FT IBUPROFEN 200 MG TABLET.

Who manufactures FT IBUPROFEN 200 MG TABLET?

FT IBUPROFEN 200 MG TABLET (NDC 70677113201) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.